Previous Close | 0.0350 |
Open | 0.0400 |
Bid | 0.0400 x N/A |
Ask | 0.0500 x N/A |
Day's Range | 0.0400 - 0.0400 |
52 Week Range | 0.0200 - 0.1750 |
Volume | |
Avg. Volume | 28,623 |
Market Cap | 2.302M |
Beta (5Y Monthly) | 0.04 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0800 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Vancouver, British Columbia--(Newsfile Corp. - April 3, 2024) - Kovo HealthTech Corporation (TSXV: KOVO) (the "Company" or "Kovo") - a leader in healthcare Billing-as-a-Service - announces a forbearance agreement with its primary lender Avonlea Ventures #2 Inc. ("AVI"), a corporation wholly-owned by Micheal Steele, a director of Kovo.Kovo's primary lender, AVI entered into a forbearance agreement (the "Forbearance Agreement") dated February 27th, 2024 in connection with the investment agreement
Vancouver, British Columbia--(Newsfile Corp. - March 7, 2024) - Kovo HealthTech Corporation (TSXV: KOVO) (the "Company" or "Kovo") — a leader in healthcare Billing-as-a-Service — today announced the appointment of Robert Galarza to the Kovo HealthTech Corporation Board of Directors, effective February 9th, 2024. Following the appointment of Mr. Galarza, the Board will comprise 5 directors, 3 of whom are independent."Robert is an excellent addition to the Kovo board of directors and we ...
Vancouver, British Columbia--(Newsfile Corp. - December 11, 2023) - Kovo HealthTech Corporation (TSXV: KOVO) (the "Company" "Kovo") a leader in healthcare technology and Billing-as-a-Service — is pleased to announce the results of its 2023 Annual General and Special Meeting ("the Meeting") of Shareholders, which was held on December 8, 2023.Shareholders unanimously re-elected Kovo's Board of Directors nominees, appointed SRCO Professional Corporation, Chartered Accountants as the Company's audit